Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study

OBJECTIVE: To determine if urinary lipoarabinomannan (LAM) may serve as a biomarker to monitor antituberculosis (TB) therapy response, and whether LAM results before and after treatment are predictive of patient outcomes. DESIGN: Prospective cohort. SETTING: Outpatient referral clinic and tertiary h...

Descripción completa

Detalles Bibliográficos
Autores principales: Drain, Paul K, Gounder, Lilishia, Grobler, Anneke, Sahid, Faieza, Bassett, Ingrid V, Moosa, Mahomed-Yunus S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401837/
https://www.ncbi.nlm.nih.gov/pubmed/25877271
http://dx.doi.org/10.1136/bmjopen-2014-006833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401837/
https://www.ncbi.nlm.nih.gov/pubmed/25877271
http://dx.doi.org/10.1136/bmjopen-2014-006833

Ejemplares similares